Amazon Seller New Product Launch Guide - 2024.pptx
Does social media matter to patinets should marketers care precise_h&p
1. Let’s get straight
to the point …
Prepared for
Does social media matter to patients?
Should pharmaceutical marketers care?
Soumya Roy, PhD. | Hall & Partners Health
Andrew Nelson | Precise
2. Our World is More Connected Than Ever
Physicians and patients have immediate access to information that influences choices
3. The pharma world is embracing customer centricity
CHANGING FROM PRODUCT & BRAND FOCUS TO PATIENT-CENTRIC
Product-driven
Brand-driven
Transactional sales model,
based on direct delivery of
product information
Focus on emotional benefits
along with clinical; big
blockbuster brands
R&D and sales driven –
huge sales force, products
sold based on the strength
of clinical attributes
Marketing driven –
marketing and sales focused
on physician loyalty and
building ‘big’ brands
2008
Customer-driven
Putting customers at the heart
of everything – including
patients and physicians;
personalized, targeted therapies
Customer driven - from pills
to solutions; putting the
customer voice at the heart
of everything
2014
4. Patients emerging as a key customer
Access to unlimited information and influencing their treatment options
59% of US adults say they looked online for health
information within the past year (Fox, 2013)
1 in 4 internet users who experienced a health crisis
in the past year sought others like them online (Fox,
2011)
1 in 5 US adults have consulted online reviews of
particular drugs or medical treatments (Fox, 2011)
35% of U.S. adults say they have gone online
specifically to try to figure out what medical condition
they or someone else might have. (Fox, Duggan, 2013)
5. Patients influence their own treatments and others
Online peer-to-peer healthcare is transforming how people feel, think, and act in
disease management
“I’ve been lurking for several months and
thought I’d finally introduce myself. My Dad
was diagnosed stage IV in May of last year at
age 64… Your posts have been an invaluable
resource to me!”
— Daughter of stage IV cancer patient
•
•
•
“The internet has made our small disease
larger and we are able to educate many
more people now.”
— Jordana Holovach
The Jacobs Cure
Passive Lurkers: patients who visit and
read disease specific social sites
Active Members: once confident, some
take the next step and contribute
Advisors: over time, some take on an
advising role and may be even be brand
advocates
6. Increasing activity suggests that social media does
matter with an impact on how patients feel, think
and act
Members
As of 25
Jul
Members
As of 28
Aug
Time/Day
US Alexa
Rating
diabetesforum.com
27,607
28,007
2.48 mins
118,248
diabetesdaily.com
99,361
99,862
2.38 mins
52,653
diabetesforums.com
45,782
46,273
2.39 mins
113,632
My Alli (GSK)
--
--
2.08 mins
131,192
Children with Diabetes (J&J)
--
--
4.37 mins
134,970
In Diabetes Forum
For every active member who posted a comment or reply,
there are another 100 Lurkers viewing the discussion* - so
pharma should care & utilize this growing social momentum
* From a random sample of 15 threads across these diabetes sites, there were 482 replies with 53,689 views suggesting a Member to Lurker ratio of 111
7. Being patient-centric involves enhancing the
patient’s digital experience
1. Assess the full
patient experience
including the challenges,
drivers, barriers
2. Understand the
drivers, barriers and
challenges in-context,
in their social space
3. Enable them with better
education, support, and
relevant promotion
Caregivers
Patient
HCPs
Payers
4. Help build true
empowerment (with right info),
engagement (disease and
lifestyle management) and
compliance (with treatments)
8. How can pharma give
rise to a patient
centric digital
experience?
Mary’s digital experience:
Understanding her journey with
diabetes
9. Meet Mary
Diabetes forum = Senior Member, joined 25th March 2013
Diagnosed: February 2013
40 year old female
Medication taken: Metformin, Synthroid & Vitamin D
Total posts: 2,755, Avg posts per day:17
Likes received
1,592 (every 1.7 posts)
Mary is a very active member of the diabetes forum community. Being new to the world of
diabetes, she starts with concerns about diet, food, self management and measurement.
She thinks of it as a number’s game with ups and downs. With confidence and control over
her BS levels, she is now an emerging advisor with detailed account of her experience that
others appreciate. Her long-term goal is to be meds free and, while initially impatient,
she now accepts her disease and know it will take time.
Her digital experience broadly falls in 3 time periods: before treatment initiation, starting
treatment and adjusting to it, and continuing treatment
10. Before treatment
Mary feels impatience with a growing sense of lack of control. Her thinking is
muddled with confusion jumping from food to numbers:
Bread…has anyone ever found a
successful substitute?
- Mary, March 29th
Okay…so let’s hear your opinion
on the whole numbers issue.
- Mary, March 31th
Small amounts of carbs, still high
numbers. Suggestions?
- Mary, April 8th
“If a doctor is stuck with the thinking that
180 is okay, then he/she is not doing a
good job of educating a diabetic. It has
been PROVEN that BG over 140 cause
damage. So, why take the advice of a
doctor who probably doesn't have
diabetes himself and is very lax in his
recommendations. After all (to quote
Jenny Ruhl of BS101) "it's not the doctor's
eyes, feet, kidneys...“
- Senior Member (66), T2D, Dx 2010
What does she do? Based on forum feedback, Mary seeks a second opinion. She finds
another doctor. She downloads bloodsugar 101 to her kindle.
11. Starting treatment
Mary feels hope in lowering her numbers, but concerned about taking a pill. Her
thinking revolves around numbers and a series of questions.
“Why the building up of the dose? If I see
my BS come down in week 3 for instance,
should I still build to the 4 per day dose?”
mess with
everyone's stomach?
“Does metformin ER always
If so, how long does it take to go away? Anything else you
can tell me about the best way to take it? Any right or
wrong way? I know he said ideally with the largest meal.”
“Do I have to worry about low blood
sugar? Should I keep carbs on hand just in
case I go below 70?”
What does she do? Takes steps towards self-management (is this control again?) -works with her doctor to assess accuracy of her BGM.
She recommends Bayer ACI over ReliOn.
12. Starting treatment – seeing results
Mary feels excitement and positive energy as her readings go down.
Her thoughts are still focused on numbers - a tangible way to measure progress.
“Since I've been on it (1550 mg Metformin)
for three weeks now, combined with a
seeing
lower numbers and I am so
excited!!!”
continued LCHF diet, I'm actually
What does she do? She actively searches information at other blogs,
forums and sites. She finds Jenny Ruhl’s blog to be a valuable source and
recommends to others.
13. Mary, continuing treatment
Mary has been seeing positive results for a while.
Mary feels confidence and then complacent – the need to control her own destiny.
“I am starting to see really nice
numbers finally… I have been on 2,000
mg. for about 8 weeks now. If I am eating
LCHF and on metformin, I don't
understand how I can eventually go off of
it and maintain stable BS. Someday, I
want to be off it and control just
with diet and exercise. If I have to
have metformin to bring me to a good
range, could I ever live without it and still
control my BS?”
“Last week, there were 3-4 days where I
didn't take my full metformin dose.
I took 1500 mg. instead of 2000 mg. I was
totally in a slump, low on pills, hadn't been
out, and had a lot going on with diabetes
anger and depression. Then, I decided
to cut my dose (stupid, I know), for
3-4 days. I then put it back up to 2000
mg. I've been fine, except for today. Now
today, I have been high all day long. (Was
normal yesterday.)”
So, what does she do? She makes inquiries about herbal alternatives berberine, guava leaf tea, aspirin therapy, milk thistle. She seeks advice
about skipping doses. She becomes non-compliant for 3-4 days before she
goes back to her regular dose.
14. A patient’s desire to regain control, reinforced by
misleading information online, can lead to noncompliance
“Mary, I did the same thing you did.
I was on a great streak with my BG
and so decided I'd try to cut
back on my metformin
(actually a combo drug - Janumet),
after I successfully eliminated
insulin. Nope, it didn't work. Had
about the same experience as you.
So right back up to my
prescribed dosage.”
- Senior Member, Dx 2005
I would not worry about it, and in
fact would wait a month or so and
try it again to see if it happens again!
I experiment with my meds a lot, with
results ranging from "aha!" to ... "okay,
okay, just kidding!“
- Senior member, Dx 2009
15. Today’s Mary: continuing treatment and compliant
6 months into her journey; her BG is controlled at 106.
Mary’s complacence has evolved into a tempered confidence.
“Has your doctor suggested
increasing your metformin?
You're not on the maximum
dose. I would watch my
carbs and increase my
metforim to 2,000 mg. a
day, if it were me”
“Just as food for thought, I didn't
feel like metformin did anything
substantial for me, until I was on
the highest dose. Since then, I
have seen really nice
improvements. At 1,000 mg.,
it did really nothing to bring me
down. Just something to
consider.”
What does she do? She is compliant. She offers advice to newly diagnosed
and confused members.
16. Identifying patterns
in Mary’s journey
leads to an
overarching model
From an individual journey to
an EXPERIENCE FRAMEWORK
to engage and empower the
patient digital experience
17. A patient experience framework to impact the digital
experience
The patient experience can be classified
into 3 distinct phases:
● Diagnosis-treatment initiation;
● During treatment;
● After treatment initiation-continuing
treatment
At each phase, patients
● Feel,
● Think, and
● Do
● Differently offering opportunity to add
value with differential engagement
strategies and tactics
18. Quantitative research to validate patient experience
framework
5 minute online survey
● Assess how patients feel-think-do
differently through the 3 phases of
Type 2 Diabetes experience
● Perceptions of usage of social media
and pharma online resources
● How pharma can provide useful
information through digital media
Respondents
● 13% before starting treatment
● 23% at treatment initiation
● 64% continuing treatment
19. Before treatment initiation , patients seek information
on disease, lifestyle, and treatment options
How can
pharma sponsored sites
be useful?
How can
social media sites
be useful?
Help me learn about
lifestyle choices I can
make (76%)
Help me learn about
lifestyle choices I can
make (57%)
Help me learn about
Tx options (67%)
Help me understand
my diagnosis & what it
means (52%)
Help me understand
my diagnosis & what
it means (67%)
Help me learn about Tx
options (43%)
Base: All Respondents Before Tx Initiation (n=21)
Q10. Now thinking about your T2D diagnosis, how can a pharmaceutical company help you to better understand and deal with
your diagnosis? Please rank your top three answers.
20. When starting treatment, patients are more focused on
drug characteristics -- safety information and unbiased
assessments
How can
pharma sponsored sites
be useful?
How can
social media sites
be useful?
Help me learn about
lifestyle choices I can
make (45%)
Provide me information
on the safety of various
treatments (45%)
Help me understand my
diagnosis & what it means
(39%)
Help me evaluate
treatments in an
unbiased way (32%)
Provide me information on
the safety of various
treatments (37%)
Educate me on the kind
of questions I can ask
my doctor (32%)
Base: All Respondents Before Tx Initiation (n=21)
Q10. Now thinking about your T2D diagnosis, how can a pharmaceutical company help you to better understand and deal with
your diagnosis? Please rank your top three answers.
21. After initiating treatment, patients are more interested
in learning about new treatments & connecting with
others like them
How can
pharma sponsored sites
be useful?
How can
social media sites
be useful?
Help me learn about
lifestyle choices I can
make (37%)
Help me connect with
others who have this
condition (44%)
Help me understand
my diagnosis & what it
means (37%)
Help me learn about
lifestyle choices I can
make (34%)
Help me learn about
new treatment
options (31%)
Help me learn about
new treatment
options (28%)
Base: All Respondents Before Tx Initiation (n=21)
Q10. Now thinking about your T2D diagnosis, how can a pharmaceutical company help you to better understand and deal with your diagnosis? Please
rank your top three answers.
22. Feelings are much more positive among those
continuing treatment
Feelings about diagnosis - NET scores, top responses
Before
Negative Feelings
Worried,
sad,
shocked,
overwhelmed
Starting
0
0
Neutral Feelings
Concerned,
vulnerable,
confused,
surprised
After
Positive Feelings
Optimistic,
curious,
secure,
energized
Base: All Respondents, Before Tx Initiation (n=21); Starting Tx Initiation (n=38); After Tx Initiation (n=105)
Q6. Thinking about your feelings about your T2D diagnosis, which of the following words would best describe the way you feel about your T2D diagnosis?
23. Activities, however, are much more prolific when
starting treatment
Actions taken by patients - % used
54%
53%
After
Starting
Before
35%
63%
74%
29%
55%
52%
15%
34%
29%
19%
14%
14%
32%
5%
24%
14%
14%
17%
5%
29%
None of
the above
Discussed with Own research
Own research Own research Discussed with Engaged with
family and
at nonat sponsored- participation
family and
online support
friends
pharmaceutical pharmaceutical
in social
friends
groups
offline
websites
websites
media sites
over social
media
Base
Q4
Diabetes
advocacy
groups
All Respondents Before Tx Initiation (n=21); Starting Tx Initiation (n=38); After Tx Initiation (n=105)
Besides your doctor, what are some sources that you have utilized to better understand and/or learn about your T2D diagnosis?
24. Utilizing an Experience
Framework to provide a
patient-centric digital
experience
Identifying opportunities for pharma
to enable, engage and empower
patients along their disease experience
24
Confidential & Proprietary. Not For Public Distribution. Do Not Copy.
25. Before treatment initiation
HOW THEY FEEL-THINK-DO
Feel
Think
Do
Shock/ denial followed by
Impatience/ Frustration
HOW TO ENGAGE
• Support services/tools to
deal with psychological
implications
• Remove stigma/self-blame
Confusion: what do the
numbers mean? what should
my diet be?
• Education focused on
diagnosis, lifestyle changes,
disease management simplicity
• Unbiased information re
drugs
Search/research,
Talk: question/gather
• Provide adequate online
resources and tools to help
with queries
• Enable easier navigation and
simpler content
26. PR Week US June 22, 2010
Will JanssenCilag's ADHD
YouTube
Video Go
Viral and Win
an Award?
Janssen-Cilag
ADHD
YouTube
video attracts
worldwide
attention.
Pharma Marketing Blog
July 20, 2010
PR Week US
June 22, 2010
http://www.youtube.com/watch?v=DaEyuicY_nM
27. Hugely successful social media campaign
● The video is now one of the most viewed pharma videos in Europe, with
more than 132,500 views in only six months
● The campaign was named Best Digital Patient Communications at the
2010 PM Society Awards
● The campaign received two nominations at the 2010 APA International
Customer Publishing Awards: Best Use of Video and Best Specialist
Communication
● Thousands of people shared the clip among their peer groups, amplifying
the brand message and campaign cut through
● Most importantly, helped improve perceptions and understanding of the
condition.
28. Starting treatment initiation
HOW THEY FEEL-THINK-DO
Feel
Think
HOW TO ENGAGE
Most vulnerable, Concern,
Seeking connection/ needing
reassurance
• Tools, apps to alleviate
concerns
• Tools to connect (CML Earth
from NVS)
Seek anchors: metrics;
Learn treatments
Tolerability/safety
Convenience
• Tools to teach adequate
usage of treatments
(injectibles, infusions, etc.)
• Simple, tangible guidelines
to measure progress
• Simple explanation of
disease and how treatment
works (MOA)
Acts to regain control: search
for the right doctor, right
treatment, right information
• Easier access to product
(help them with treatment
plan; coordinated care)
• Help find doctors
Do
30. After treatment initiation
HOW THEY FEEL-THINK-DO
HOW TO ENGAGE
Complacent, confident,
acceptance (can be resigned
or peaceful)
• Tools to emphasize and
address compliance
• Enable connection with
advocacy groups
Risk-averse, questioning,
valuing personal knowledge
and experience
Feel
• On-going FAQs re
compliance
• On-going tools for
answering questions about
disease management/
switching/nutrition (AZ
customer portal)
seeking agency,
experimenting, questioning,
gathering
• Easy access to new
products/pipeline products
• Financial support
• Patient advocacy group
• Clinical trial enrollment
Think
Do
31. Key takeaways
● Utilize social and digital media to impact patient experience of disease
and brand, beyond simple advertisements
● Use social media monitoring + primary research to learn how to better
tailor their patient engagement strategies and tactics
● Provide enabling tools that are entertaining and relevant (e.g. entertain
with games that tap into a different part of the brain) but also make it
relevant to the phase in their journey
● Measure effectiveness of social media initiatives and apply strategic
listening to evaluate campaigns along with traditional research
● Utilize social media to inform different teams, not just marketing;
include patient support teams, product development, etc.
● Don’t put your customers into a “digital bucket” just because their
conversations are in social; involve and integrate qualitative and
quantitative primary research – we still have to ask questions
to get to the “Why’s?”
32. Questions?
Soumya Roy
Andrew Nelson
Todd Grossman
Managing Partner, Health
Healthcare Director
Managing Director, Americas
Hall & Partners
Precise
Precise
s.roy@hallandpartners.com
andrew.nelson@precise.co.uk
todd.grossman@precise.us.com
32
Confidential & Proprietary. Not For Public Distribution. Do Not Copy.